Breaking a Vicious Cycle

被引：97

作者：

Hayes, Daniel F. ^{[1
]}

Allen, Jef ^{[2
]}

Compton, Carolyn ^{[3
]}

Gustavsen, Gary ^{[4
]}

Leonard, Debra G. B. ^{[5
]}

McCormack, Robert ^{[6
]}

Newcomer, Lee ^{[7
]}

Pothier, Kristin ^{[4
]}

Ransohof, David ^{[8
]}

Schilsky, Richard L. ^{[9
]}

Sigal, Ellen ^{[2
]}

Taube, Sheila E. ^{[10
]}

Tunis, Sean R. ^{[11
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[2] Friends Canc Res, Washington, DC 20036 USA

[3] Crit Path Inst, Tucson, AZ 85257 USA

[4] Hlth Adv, Weston, MA 02090 USA

[5] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA

[6] Veridex, Raritan, NJ 08869 USA

[7] UnitedHealthCare, Minnetonka, MN 55343 USA

[8] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA

[9] Amer Soc Clin Oncol, Alexandria, VA 22314 USA

[10] ST Consulting, Bethesda, MD 20817 USA

[11] Ctr Med Technol Policy, Baltimore, MD 21202 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2013年 / 5卷 / 196期

关键词：

TUMOR-MARKERS; AMERICAN SOCIETY; CLINICAL UTILITY; CANCER; BIOMARKERS; INDUSTRY; TRIALS; DESIGN; ASSAY;

D O I：

10.1126/scitranslmed.3005950

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Despite prodigious advances in tumor biology research, few tumor-biomarker tests have been adopted as standard clinical practice. This lack of reliable tests stems from a vicious cycle of undervaluation, resulting from inconsistent regulatory standards and reimbursement, as well as insufficient investment in research and development, scrutiny of biomarker publications by journals, and evidence of analytical validity and clinical utility. We of er recommendations designed to serve as a roadmap to break this vicious cycle and call for a national dialogue, as changes in regulation, reimbursement, investment, peer review, and guidelines development require the participation of all stakeholders.

引用

页数：7

共 50 条

[41] A Complex Interplay Between Nutrition and Alcohol Use Disorder: Implications for Breaking the Vicious Cycle
White, Brooke
Sirohi, Sunil
CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (23) : 1822 - 1837
[42] HUMAN-RESOURCE DEVELOPMENT - A KEY TO BREAKING THE VICIOUS CYCLE IN DEVELOPING-NATIONS
AWOTUAEFEBO, EB
PROGRAMMED LEARNING & EDUCATIONAL TECHNOLOGY, 1984, 21 (01): : 46 - 51
[43] Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa
Muesken, Mathias
Pawar, Vinay
Schwebs, Timo
Baehre, Heike
Felgner, Sebastian
Weiss, Siegfried
Haeussler, Susanne
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (12)
[44] Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation
Hu, Zhuoyu
Chen, Xiangdong
Hu, Qi
Zou, Menglong
Liu, Zhimin
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2025, 13 (02):
[45] Breaking "vicious cycle"? The role of miR-223 in breast cancer metastasis to bone
Shan, Zhen
Li, Wen
Lin, Ying
Zeng, Huijuan
Qi, Yunling
Lin, Zefei
Fan, Yuanjian
CANCER RESEARCH, 2020, 80 (04)
[46] "Breaking a vicious cycle": the reproduction of ableism in higher education and its impact on students with disabilities
Goodall, Gemma
Mjoen, Odd Morten
Witso, Aud Elisabeth
Horghagen, Sissel
Kvam, Lisbeth
FRONTIERS IN EDUCATION, 2024, 9
[47] Targeting a vicious cycle
Nature, 2012, 490 (7421) : 449 - 449
[48] A vicious, indeterminate cycle?
不详
PSYCHOLOGIST, 2022, 35 : 12 - 12
[49] Another vicious cycle?
Serb, C
HOSPITALS & HEALTH NETWORKS, 1998, 72 (20): : 24 - +
[50] V IS FOR VICIOUS CYCLE
Shilling, A. Gary
FORBES, 2009, 184 (10): : 126 - 126

← 1 2 3 4 5 →